These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7999882)
21. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780 [TBL] [Abstract][Full Text] [Related]
22. [Induction of biological protection in pigs against infection with Aujeszky disease virus by vaccination with large doses of live or inactivated vaccines]. Zuffa A Vet Med (Praha); 1986 Feb; 31(2):83-94. PubMed ID: 3008403 [TBL] [Abstract][Full Text] [Related]
23. Adjuvant properties of propionibacterium avidum KP-40 in vaccination against endemic viral and bacterial infections. I. Swine immunized with live attenuated Aujeszky's disease virus vaccine and experimentally infected with virulent viruses. Markowska-Daniel I; Pejsak Z; Szmigielski S; Jeljaszewicz J; Pulverer G Zentralbl Bakteriol; 1992 Dec; 277(4):529-37. PubMed ID: 1338942 [TBL] [Abstract][Full Text] [Related]
24. Protection of pigs against Aujeszky's disease by DNA vaccination. Gerdts V; Jöns A; Makoschey B; Visser N; Mettenleiter TC J Gen Virol; 1997 Sep; 78 ( Pt 9)():2139-46. PubMed ID: 9291999 [TBL] [Abstract][Full Text] [Related]
25. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related]
26. Measurement of isotype-specific antibody responses to Aujeszky's disease virus in sera and mucosal secretions of pigs. Kimman TG; Brouwers RA; Daus FJ; van Oirschot JT; van Zaane D Vet Immunol Immunopathol; 1992 Feb; 31(1-2):95-113. PubMed ID: 1315087 [TBL] [Abstract][Full Text] [Related]
27. [Immunization of cattle against Aujeszky's disease with inactivated adjuvant vaccine]. Zuffa A; Brányik A; Zuffová J; Melcický G; Hirko M; Blecha J; Valent L Vet Med (Praha); 1981 May; 26(5):257-70. PubMed ID: 6267762 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of parenteral vaccination methods with glycoproteins against Aujeszky's disease in pigs. Vanderpooten A; Goddeeris B; De Roose P; Hendrickx L; Biront P; Desmettre P Vet Microbiol; 1997 Apr; 55(1-4):81-9. PubMed ID: 9220599 [TBL] [Abstract][Full Text] [Related]
30. Vaccination experiments in cattle with a live and with an inactivated Aujeszky's disease virus vaccine. Akkermans JP; Wirahadiredja RM; Rondhuis PR; Jakubik J Zentralbl Veterinarmed B; 1979 Feb; 26(1):49-60. PubMed ID: 220817 [No Abstract] [Full Text] [Related]
31. [Vaccination of piglets of different ages with inactivated Aujeszky's disease vaccine]. Jakubik J; Wittmann G Berl Munch Tierarztl Wochenschr; 1979 Sep; 92(17):343-5. PubMed ID: 231429 [No Abstract] [Full Text] [Related]
32. Formaldehyde-fixed cells infected with pseudorabies virus conferred resistance against Aujeszky's disease. Tanaka S; Imamura T; Matsui H; Sakaguchi M; Matsuo K; Yamamoto M J Vet Med Sci; 1994 Dec; 56(6):1177-9. PubMed ID: 7696414 [TBL] [Abstract][Full Text] [Related]
33. [Possibilities of vaccination with an inactivated virus via the respiratory tract as studied in the Aujesky virus--white mouse system]. Neukirch M; Bauer K Zentralbl Veterinarmed B; 1977 Jan; 24(1):63-74. PubMed ID: 189533 [No Abstract] [Full Text] [Related]
34. Effect of vaccination on shedding of Aujeszky's disease virus in experimentally infected pigs and role of vaccination in herd health programmes. Smíd B; Rodák L; Valícek L; Sabo A; Matis J Acta Vet Hung; 1994; 42(2-3):391-6. PubMed ID: 7810436 [No Abstract] [Full Text] [Related]
35. Protective immunity induced by systemic and mucosal delivery of DNA vaccine expressing glycoprotein B of pseudorabies virus. Yoon HA; Han YW; Aleyas AG; George JA; Kim SJ; Kim HK; Song HJ; Cho JG; Eo SK J Microbiol Biotechnol; 2008 Mar; 18(3):591-9. PubMed ID: 18388482 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of various non-oily adjuvants in immunization against the Aujeszky's disease (pseudorabies) virus. Puentes E; Cancio E; Eiras A; Nores MV; Aguilera A; Regueiro BJ; Seoane R Zentralbl Veterinarmed B; 1993 Jul; 40(5):353-65. PubMed ID: 8237208 [TBL] [Abstract][Full Text] [Related]
37. [The effect of vaccination on the intrauterine transmission of Aujeszky's disease virus in sows]. Smíd B; Valícek L; Mensík J Vet Med (Praha); 1981 Mar; 26(3):155-63. PubMed ID: 6266115 [TBL] [Abstract][Full Text] [Related]
38. Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge. Moriyama M; Chino S; Ichinohe T Vaccine; 2017 Feb; 35(7):1001-1007. PubMed ID: 28111142 [TBL] [Abstract][Full Text] [Related]
39. Protective antibody responses against A(H1N1)pdm09 primed by infection and recalled by intranasal vaccination. Ikeda K; Ainai A; Hasegawa H Vaccine; 2015 Nov; 33(45):6066-9. PubMed ID: 26432916 [TBL] [Abstract][Full Text] [Related]
40. Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabies. Wang J; Wang Y; Zhang E; Zhou M; Lin J; Yang Q Microb Cell Fact; 2019 Jun; 18(1):103. PubMed ID: 31170996 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]